[1]
B. C. Kataria, A. S. Pandya, A. K. Panchasara, P. J. Panchal, and M. R. Parmar, “Drug lag for antineoplastic and immunomodulating agent approvals in India compared with the US and EU approvals”, Int J Basic Clin Pharmacol, vol. 5, no. 2, pp. 335–340, Dec. 2016.